Alfred Sandrock Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alfred Sandrock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Alfred Sandrock for March 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 815 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 628 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,569 | 0 | 6,828 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 398 | 0 | 1,062 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,375 | 0 | 4,960 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 662 | 0 | 1,460 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,103 | 0 | 6,335 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 738 | 0 | 628 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,841 | 0 | 8,397 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 384 | 105,508 | 10,014 | 10.4 K to 10 K (-3.69 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 815 | 0 | 10,398 | 9.6 K to 10.4 K (+8.50 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.60 | 296 | 81,282 | 9,583 | 9.9 K to 9.6 K (-3.00 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 628 | 0 | 9,879 | 9.3 K to 9.9 K (+6.79 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 739 | 203,048 | 9,251 | 10 K to 9.3 K (-7.40 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,569 | 0 | 9,990 | 8.4 K to 10 K (+18.63 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 727 | 199,751 | 8,421 | 9.1 K to 8.4 K (-7.95 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 284.75 | 188 | 53,533 | 9,148 | 9.3 K to 9.1 K (-2.01 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 398 | 0 | 9,336 | 8.9 K to 9.3 K (+4.45 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 287.63 | 647 | 186,097 | 8,938 | 9.6 K to 8.9 K (-6.75 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,375 | 0 | 9,585 | 8.2 K to 9.6 K (+16.75 %) |